2020 Virtual ESMO Review
Playback speed
10 seconds
2020 ESMO Update on Targeted Therapy in NSCLC: Does ADAURA Trial Suggest Clinically Meaningful Improvement in CNS DFS With Osimertinib? Does Heavily Pretreated KRAS G12C-Mutant NSCLC Respond to Sotorasib?
By
2020 Virtual ESMO Review
FEATURING
Ibiayi Dagogo-Jack
By
2020 Virtual ESMO Review
FEATURING
Ibiayi Dagogo-Jack
177 views
November 25, 2020
Comments 0
Login to view comments.
Click here to Login
Videos